Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: BMY, JNJ, PFE, NVS, GSK, ABT
17 Dezember 2008 - 3:20PM
PR Newswire (US)
DALLAS, Dec. 17 /PRNewswire/ -- BeaconEquity.com announces the
availability of Trade Alerts on stocks making news today. Investors
can view all of the daily trading notes for free by visiting:
http://www.beaconequity.com/m Today's Trade Alerts include:
Bristol-Myers Squibb Co. (NYSE:BMY), Johnson & Johnson
(NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (NYSE: NVS),
GlaxoSmithKlne plc (NYSE:GSK) and Abbott Laboratories (NYSE:ABT).
Join the fastest growing investment community at:
http://www.stockhideout.com/ See what Cramer has to say about these
stocks at: http://maddmoney.net/ BeaconEquity.com's Trade Alerts
are brief analyses on the active stocks each day that are affecting
the markets. These include breaking news, insider activity, recent
52-week highs/lows, technical breakouts, and other market driving
information. Beacon is the authority on research in the small cap
sector, and our analysts strive each day to find the stocks that
are poised to be the biggest movers before the rest of the market
is aware of them. We encourage investors to subscribe to our FREE
newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m BeaconEquity.com is one of the
industry's largest small cap research providers. Beacon strives to
provide a balanced view of many promising small cap companies that
would otherwise fall under the radar of the typical Wall Street
investor. We provide investors with an excellent first step in
their research and due diligence by providing daily trading ideas,
and consolidating the publicly available information available on
them. For more information on Beacon Research, please visit:
http://www.beaconequity.com/m CRD# 1755680 BeaconEquity.com
Disclosure BeaconEquity.com is not a registered investment advisor
and nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. BeaconEquity.com is a
wholly owned entity of BlueWave Advisors, LLC, a financial public
relations firm. Please read our report and visit our website,
BeaconEquity.com, for complete risks and disclosures. Beacon Equity
Research Jeff Bishop, (469)-252-3505 Reuben Sushman of Beacon
Equity Research is a member of the National Association of
Securities Dealers, CRD number 1755680. Available Topic Expert(s):
For information on the listed expert(s), click appropriate link.
JEFF BISHOP
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781
DATASOURCE: BeaconEquity.com CONTACT: Jeff Bishop, Beacon Equity
Research, +1-469-252-3505, Web Site: http://maddmoney.net/
Copyright